Literature DB >> 18045945

Cellular entry of lymphocytic choriomeningitis virus.

Jillian M Rojek1, Mar Perez, Stefan Kunz.   

Abstract

In contrast to most enveloped viruses that enter the host cell via clathrin-dependent endocytosis, the Old World arenavirus lymphocytic choriomeningitis virus (LCMV) enters cells via noncoated vesicles that deliver the virus to endosomes, where pH-dependent membrane fusion occurs. Here, we investigated the initial steps of LCMV infection. We found that the attachment of LCMV to its cellular receptor alpha-dystroglycan occurs rapidly and is not dependent on membrane cholesterol. However, subsequent virus internalization is sensitive to cholesterol depletion, indicating the involvement of a cholesterol-dependent pathway. We provide evidence that LCMV entry involves an endocytotic pathway that is independent of clathrin and caveolin and that does not require the GTPase dynamin. In addition, neither the structural integrity nor the dynamics of the actin cytoskeleton are required for infection. These findings indicate that the prototypic Old World arenavirus LCMV uses a mechanism of entry that is different from clathrin-mediated endocytosis, which is used by the New World arenavirus Junin virus, and pathways used by other enveloped viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045945      PMCID: PMC2224412          DOI: 10.1128/JVI.01331-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

Review 1.  Model systems, lipid rafts, and cell membranes.

Authors:  Kai Simons; Winchil L C Vaz
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

2.  Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus.

Authors:  Stefan Kunz; Noemí Sevilla; Jillian M Rojek; Michael B A Oldstone
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

3.  Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic.

Authors:  Lucas Pelkmans; Thomas Bürli; Marino Zerial; Ari Helenius
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

Review 4.  How viruses enter animal cells.

Authors:  Alicia E Smith; Ari Helenius
Journal:  Science       Date:  2004-04-09       Impact factor: 47.728

5.  Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses.

Authors:  M J Buchmeier; H A Lewicki; O Tomori; M B Oldstone
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

6.  Uptake pathway of polyomavirus via ganglioside GD1a.

Authors:  Joanna Gilbert; Thomas Benjamin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events.

Authors:  Vilja Pietiäinen; Varpu Marjomäki; Paula Upla; Lucas Pelkmans; Ari Helenius; Timo Hyypiä
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

8.  Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry.

Authors:  Pranav Danthi; Marie Chow
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Requirements for CEACAMs and cholesterol during murine coronavirus cell entry.

Authors:  Edward B Thorp; Thomas M Gallagher
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 10.  Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms.

Authors:  Robert G Parton; Ayanthi A Richards
Journal:  Traffic       Date:  2003-11       Impact factor: 6.215

View more
  49 in total

Review 1.  Novel approaches in anti-arenaviral drug development.

Authors:  Andrew M Lee; Antonella Pasquato; Stefan Kunz
Journal:  Virology       Date:  2010-12-22       Impact factor: 3.616

2.  The properties of the unique age-associated B cell subset reveal a shift in strategy of immune response with age.

Authors:  Susan L Swain; Olivia Kugler-Umana; Yi Kuang; Wenliang Zhang
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

3.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication.

Authors:  Katrin Schlie; Anna Maisa; Frank Lennartz; Ute Ströher; Wolfgang Garten; Thomas Strecker
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

5.  Sodium hydrogen exchangers contribute to arenavirus cell entry.

Authors:  Masaharu Iwasaki; Nhi Ngo; Juan C de la Torre
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

6.  Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.

Authors:  Nhi Ngo; Kristina Schimmelpfeng Henthorn; Maria Isabel Cisneros; Beatrice Cubitt; Masaharu Iwasaki; Juan C de la Torre; Juan Lama
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

Review 7.  Endocytosis of viruses and bacteria.

Authors:  Pascale Cossart; Ari Helenius
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-08-01       Impact factor: 10.005

8.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

9.  Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment.

Authors:  Joseph P Klaus; Jason Botten
Journal:  J Vis Exp       Date:  2016-03-02       Impact factor: 1.355

10.  A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells.

Authors:  Sarah Gold; Paul Monaghan; Peter Mertens; Terry Jackson
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.